Related Experiment Video

Updated: Feb 3, 2026

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats
08:09

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats

Published on: May 20, 2020

9.8K

Single vs. repeated matrix metalloproteinase-13 knockdown with intra-articular short interfering RNA administration

Ryosuke Nakagawa1, Ryuichiro Akagi1, Satoshi Yamaguchi1

  • 1a Department of Orthopaedic Surgery , Graduate School of Medical and Sciences, Chiba University , Chiba , Japan.

Connective Tissue Research
|October 23, 2018
PubMed

Insights

Short interfering RNA (siRNA) targeting matrix metalloproteinase-13 (Mmp-13) reduced Mmp-13 levels for one week in a mouse osteoarthritis model. Repeated siRNA injections did not offer additional benefits over a single dose for cartilage protection.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation.
  • Matrix metalloproteinase-13 (Mmp-13) plays a key role in cartilage breakdown.
  • Short interfering RNA (siRNA) offers a potential therapeutic strategy for OA by targeting specific genes like Mmp-13.

Purpose of the Study:

  • To determine the duration of the therapeutic effect of a single intra-articular injection of Mmp-13 siRNA in a mouse OA model.
  • To evaluate if repeated Mmp-13 siRNA injections provide additional benefits in suppressing cartilage degradation compared to a single injection.

Main Methods:

  • A destabilization of the medial meniscus (DMM) mouse model was used to induce OA.
  • Intra-articular injection of Mmp-13 siRNA or non-targeted control siRNA was administered one week post-DMM.
  • Mmp-13 mRNA levels were measured using quantitative polymerase chain reaction (qPCR) at 2, 3, and 6 weeks.
  • Histological assessment of articular cartilage was performed at 8 weeks post-DMM surgery.

Main Results:

  • Mmp-13 siRNA significantly reduced Mmp-13 mRNA levels by 40% at 2 weeks post-injection (p=0.04), returning to baseline by 3 weeks.
  • All Mmp-13 siRNA-treated groups showed significant histological improvement in cartilage compared to controls (p < 0.05).
  • No significant difference in cartilage protection was observed between single and multiple siRNA injection groups.

Conclusions:

  • The therapeutic effect of intra-articular Mmp-13 siRNA in the knee joint lasts for at least one week.
  • Repeated Mmp-13 siRNA injections do not confer additional therapeutic benefits for cartilage protection in this OA model.
  • Single-dose siRNA therapy demonstrates potential for managing OA, with implications for treatment frequency.
Keywords:
Matrix metalloproteinase-13RNAosteoarthritissmall interfering

More Related Videos

Detection of Functional Matrix Metalloproteinases by Zymography09:30

Detection of Functional Matrix Metalloproteinases by Zymography

Published on: November 8, 2010

85.0K
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

15.1K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
89.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.1K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.7K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.5K
One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model01:12

One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Extravascular administration, such as oral or intramuscular routes, is a non-invasive drug delivery method, often preferred for ease and patient compliance. A key factor here is absorption, which dictates how quickly and effectively the drug enters the bloodstream from the administration site. Absorption follows either zero-order or first-order kinetics.
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
373